MiR-675 and Ovarian Cancer
Author Information
Author(s): Zhao Xinxin, Liu Ziping, Li Yongshuai, Song Shiji, Wang Baojin, Pfeffer Lawrence M., Zhang Wenjing, Yue Junming
Primary Institution: University of Tennessee Health Science Center
Hypothesis
This study aims to investigate the role of miR-675 in ovarian cancer tumor progression and metastasis.
Conclusion
MiR-675 expression suppresses primary ovarian tumor growth and metastasis by targeting TGFβ1 and inhibiting epithelial to mesenchymal transition.
Supporting Evidence
- MiR-675 expression inhibits primary tumor growth and metastasis in an orthotopic OC mouse model.
- Functional assays revealed significant inhibition of cell proliferation, migration, and invasion by miR-675.
- MiR-675 enhances the apoptotic effect of paclitaxel and carboplatin, suggesting potential for combination therapy.
Takeaway
MiR-675 helps stop ovarian cancer from growing and spreading by blocking certain signals that help tumors grow.
Methodology
The study used in vitro OC cell lines and an in vivo orthotopic mouse model to assess the effects of miR-675 on tumor growth and metastasis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website